NF Midwest Co-Funds New NF2 Gene Therapy Project

Thanks to the support of our donors, NF Midwest is proud to be one of four NF organizations collaborating to fund a new  NF2 Gene Therapy project.

NF Midwest, NF2 BioSolutions, NF Northeast, and NF Michigan have combined forces to fund a USD$100,000 Gene therapy project at Dr. Wade Clapp’s Lab at the Indiana University.

This project will test several vectors on NF2 mice. (Vectors are sort of the vehicle that delivers the material to change a gene to the correct cells – Learn More About Vectors ). These vectors were designed by two separate labs at both University of Massachusetts and Nationwide Children’s Hospital. The UMass project was funded last year by another collaborative USD$65,000 grant from NF Northeast, NF Midwest, and NF2 BioSolutions. The project at Nationwide Children’s Hospital was funded by a three year USD$330,000 grant from NF2 BioSolutions.

Recent Posts

  • Meet the 2026 NF Midwest Scholarship Recipients 

    The NF Midwest Scholarship Program is proud to celebrate another year of supporting students with neurofibromatosis as they work toward their educational dreams.  Each year, NF Midwest awards scholarships to students across our six-state region. These students are pursuing their goals while also navigating life with NF, and we are honored to play a small... Read More
  • Why Clinical Trials Matter, and Why They Matter Especially for NF

    Every treatment that exists today: every medication, every therapy, every breakthrough, started somewhere. It started with a question, a hypothesis, and eventually, a clinical trial. May 20 is National Clinical Trials Day, a moment to recognize the remarkable system that turns scientific ideas into real-world answers. For the NF community (patients, families, caregivers, and advocates)... Read More

Responses

Respond

Your email address will not be published. Required fields are marked *